Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating Icotinib and Chemotherapy in EGFR-mutated NSCLC
NCT02737774Phase 2Unknown
- Sponsor
- Henan Cancer Hospital
- Start
- Apr 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethinylestradiol + levonorgestrel in lung adenocarcinoma, sponsored by Henan Cancer Hospital. Status: unknown.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02737774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737774.